BioSpace News Archive

Business

EQRx and CM Life Sciences III Announce Effectiveness of Form S-4 Registration Statement and Stockholder Meeting Details to Vote on Proposed Business Combination

EQRx today announced that the U.S. Securities and Exchange Commission (“SEC”) has declared CM Life Sciences III’s registration statement on Form S-4 relating to the previously announced business combination agreement between EQRx and CM Life Sciences III effective.

December 2, 2021
·
8 min read
Biotech Beach

Aurora Spine Corporation Retains PRIA Healthcare to Improve Patient Access to Proprietary Products

Aurora Spine Corporation today announced it has retained PRIA Healthcare to assist in patient access for its proprietary products, including ZIP® and SiLO.

December 2, 2021
·
4 min read
Business

Monte Rosa Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer

Monte Rosa Therapeutics, Inc., a biotechnology company developing novel molecular glue degrader medicines, announced the promotion of Jullian Jones, Ph.D., J.D., MBA, to Chief Business Officer.

December 2, 2021
·
2 min read
Deals

Omeros Announces Agreement to Sell OMIDRIA® Franchise to Rayner Surgical in a Transaction Valued in Excess of $1 Billion

Omeros Announces Agreement to Sell OMIDRIA ® Franchise to Rayner Surgical in a Transaction Valued in Excess of $1 Billion.

December 2, 2021
·
9 min read
Heru Selected to Present Among Titans in Healthcare, Medicine, Science and Business at the 10th Annual Forbes Healthcare Summit

Heru Selected to Present Among Titans in Healthcare, Medicine, Science and Business at the 10th Annual Forbes Healthcare Summit.

December 2, 2021
·
3 min read
Biomind Labs to Participate in the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6, 2021

Biomind Labs Inc. is pleased to announce that Alejandro Antalich, Chief Executive Officer, and Dr. Draulio Barros de Araujo, Scientific and Clinical Advisor, will participate at the 2nd Annual H.C. Wainwright Psychedelics Conference being held virtually on Monday, December 6, 2021.

December 2, 2021
·
5 min read
Business

Aizon Names New Strategic Advisory Board with Esteemed Pharma Experts and Industry Veterans

Aizon, an enterprise AI software provider, announced today the creation of a Strategic Advisory Board (SAB) made up of four world-renowned executives from the pharmaceutical and healthcare industries.

December 2, 2021
·
3 min read
Genetown

SOTIO Secures €280m of Funding to Expand and Advance Clinical Pipeline

SOTIO Biotech, a clinical stage immuno-oncology companyowned by PPF Group,announced that is has secured€280m of funding to significantly expand and advance its clinical pipeline, including its lead assetSOT101, an IL-15 superagonist, and three new clinical programs until the end of 2023.

December 2, 2021
·
3 min read
Immutep Reports Good Safety from First Five Patients in Triple Combination Therapy Efti Study, Insight-003

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune disease, announces the first five patients have been treated in the INSIGHT-003 study.

December 2, 2021
·
2 min read
BioForest

Cocrystal Pharma to Discuss Progress with COVID-19 Antiviral Programs and Clinical Strategy During Noble Capital Markets’ Channelchek Virtual Roadshow

Cocrystal Pharma, Inc. announces that President and interim CEO Sam Lee, Ph.D. and CFO and interim CEO James Martin will present a company overview in the Noble Capital Markets Virtual Roadshow Series presented by Channelchek.

December 2, 2021
·
4 min read